Provided by Tiger Fintech (Singapore) Pte. Ltd.

Omeros

3.07
-0.0200-0.65%
Volume:181.20K
Turnover:556.10K
Market Cap:179.88M
PE:-1.16
High:3.16
Open:3.08
Low:3.01
Close:3.09
Loading ...

Omeros Stock Falls to 52-Week Low on 1Q Results, Company Pauses Trial

Dow Jones
·
17 May

Omeros Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

BRIEF-Omeros Corporation Q1 Net Income USD -33.5 Million

Reuters
·
16 May

Omeros Q1 EPS $(0.58) Misses $(0.57) Estimate

Benzinga
·
16 May

Omeros Corporation Reports Q1 2025 Net Loss of $33.5M, EPS Improves to $0.58 from $0.63; OMIDRIA Royalties Drop to $6.7M

Reuters
·
16 May

Omeros Corporation Q1 EPS USD -0.58

THOMSON REUTERS
·
16 May

Omeros Corp expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
14 May

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Omeros Corporation to Announce First Quarter Financial Results

Reuters
·
13 May

Top Midday Decliners

MT Newswires Live
·
13 May

Omeros Shares Drop After Notes Conversions

Dow Jones
·
13 May

Omeros to Exchange 2026 Convertible Notes for New 2029 Notes

MT Newswires Live
·
12 May

BRIEF-Omeros Corporation to acquire $80.5 million of its convertible senior notes

Reuters
·
12 May

Omeros Corporation Announces Agreements to Acquire $80.5 Million of Its Convertible Senior Notes Due 2026

THOMSON REUTERS
·
12 May

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
07 May

FDA Accepts Resubmission of Bla for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (Ta-Tma) and Assigns Late September Pdufa Date

THOMSON REUTERS
·
06 May

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
11 Apr

Omeros Announces the Omeros Oncology Clinical Steering Committee for Aml to Help Guide Omeros’ Proprietary Oncotox-Aml Clinical Program

THOMSON REUTERS
·
10 Apr

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases

Business Wire
·
08 Apr